| Symbol |
Name |
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ACACA
|
acetyl-CoA carboxylase alpha
|
|
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT1S1
|
AKT1 substrate 1 (proline-rich)
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
AMBRA1
|
autophagy/beclin-1 regulator 1
|
|
APC
|
adenomatous polyposis coli
|
|
AR
|
androgen receptor
|
|
ATF4
|
activating transcription factor 4
|
|
ATG13
|
autophagy related 13
|
|
ATP1B2
|
ATPase, Na+/K+ transporting, beta 2 polypeptide
|
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BECN1
|
beclin 1, autophagy related
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BTRC
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
|
C2ORF68
|
chromosome 2 open reading frame 68
|
|
CAD
|
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CCDC28B
|
coiled-coil domain containing 28B
|
|
CCND1
|
cyclin D1
|
|
CCNG2
|
cyclin G2
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD247
|
CD247 molecule
|
|
CDC42
|
cell division cycle 42
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CHRM2
|
cholinergic receptor, muscarinic 2
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CLDN2
|
claudin 2
|
|
CRTC2
|
CREB regulated transcription coactivator 2
|
|
CSK
|
c-src tyrosine kinase
|
|
CSNK1A1
|
casein kinase 1, alpha 1
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CUL4B
|
cullin 4B
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
DDIT4
|
DNA-damage-inducible transcript 4
|
|
DDIT4L
|
DNA-damage-inducible transcript 4-like
|
|
DEK
|
DEK proto-oncogene
|
|
DEPTOR
|
DEP domain containing MTOR-interacting protein
|
|
DGKZ
|
diacylglycerol kinase, zeta
|
|
EDN1
|
endothelin 1
|
|
EEF2
|
eukaryotic translation elongation factor 2
|
|
EEF2K
|
eukaryotic elongation factor 2 kinase
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF3I
|
eukaryotic translation initiation factor 3, subunit I
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
ENG
|
endoglin
|
|
EPHB4
|
EPH receptor B4
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
EREG
|
epiregulin
|
|
F10
|
coagulation factor X
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FAS
|
Fas cell surface death receptor
|
|
FASN
|
fatty acid synthase
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FKBP1A
|
FK506 binding protein 1A, 12kDa
|
|
FKBP8
|
FK506 binding protein 8, 38kDa
|
|
FLCN
|
folliculin
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FNIP1
|
folliculin interacting protein 1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
GABARAP
|
GABA(A) receptor-associated protein
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GNB1
|
guanine nucleotide binding protein (G protein), beta polypeptide 1
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GNG2
|
guanine nucleotide binding protein (G protein), gamma 2
|
|
GOLPH3
|
golgi phosphoprotein 3 (coat-protein)
|
|
GPLD1
|
glycosylphosphatidylinositol specific phospholipase D1
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSPT1
|
G1 to S phase transition 1
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HMOX1
|
heme oxygenase 1
|
|
HNRNPA1
|
heterogeneous nuclear ribonucleoprotein A1
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HTR6
|
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IFN1@
|
interferon, type 1, cluster
|
|
IFNG
|
interferon, gamma
|
|
IGBP1
|
immunoglobulin (CD79A) binding protein 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL10
|
interleukin 10
|
|
IL12B
|
interleukin 12B
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL4
|
interleukin 4
|
|
ILK
|
integrin-linked kinase
|
|
INS
|
insulin
|
|
IPMK
|
inositol polyphosphate multikinase
|
|
IQGAP1
|
IQ motif containing GTPase activating protein 1
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGAV
|
integrin, alpha V
|
|
JAG1
|
jagged 1
|
|
JUNB
|
jun B proto-oncogene
|
|
KDR
|
kinase insert domain receptor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KL
|
klotho
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLK4
|
kallikrein-related peptidase 4
|
|
KPNA1
|
karyopherin alpha 1 (importin alpha 5)
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LACRT
|
lacritin
|
|
LEP
|
leptin
|
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
|
|
MAF1
|
MAF1 homolog (S. cerevisiae)
|
|
MAP1LC3B
|
microtubule-associated protein 1 light chain 3 beta
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPT
|
microtubule-associated protein tau
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MIR100
|
microRNA 100
|
|
MIR101-1
|
microRNA 101-1
|
|
MIR144
|
microRNA 144
|
|
MIR148A
|
microRNA 148a
|
|
MIR155
|
microRNA 155
|
|
MIR199A1
|
microRNA 199a-1
|
|
MIR199B
|
microRNA 199b
|
|
MIR21
|
microRNA 21
|
|
MIR99A
|
microRNA 99a
|
|
MIR99B
|
microRNA 99b
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MLST8
|
MTOR associated protein, LST8 homolog (S. cerevisiae)
|
|
MLXIP
|
MLX interacting protein
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MSTN
|
myostatin
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCBP2
|
MYC binding protein 2, E3 ubiquitin protein ligase
|
|
NAA10
|
N(alpha)-acetyltransferase 10, NatA catalytic subunit
|
|
NAPA
|
N-ethylmaleimide-sensitive factor attachment protein, alpha
|
|
NF1
|
neurofibromin 1
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NOV
|
nephroblastoma overexpressed
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NUP153
|
nucleoporin 153kDa
|
|
NUP214
|
nucleoporin 214kDa
|
|
PABPC1
|
poly(A) binding protein, cytoplasmic 1
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PELP1
|
proline, glutamate and leucine rich protein 1
|
|
PHLPP1
|
PH domain and leucine rich repeat protein phosphatase 1
|
|
PIH1D1
|
PIH1 domain containing 1
|
|
PIK3C3
|
phosphatidylinositol 3-kinase, catalytic subunit type 3
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIK3R3
|
phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PLK2
|
polo-like kinase 2
|
|
PML
|
promyelocytic leukemia
|
|
POLDIP3
|
polymerase (DNA-directed), delta interacting protein 3
|
|
PPARGC1B
|
peroxisome proliferator-activated receptor gamma, coactivator 1 beta
|
|
PPP1R15A
|
protein phosphatase 1, regulatory subunit 15A
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PPP2R2B
|
protein phosphatase 2, regulatory subunit B, beta
|
|
PPP5C
|
protein phosphatase 5, catalytic subunit
|
|
PREX1
|
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCH
|
protein kinase C, eta
|
|
PRKCSH
|
protein kinase C substrate 80K-H
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
RAB4A
|
RAB4A, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAP1B
|
RAP1B, member of RAS oncogene family
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
|
RB1
|
retinoblastoma 1
|
|
RB1CC1
|
RB1-inducible coiled-coil 1
|
|
RET
|
ret proto-oncogene
|
|
RHEB
|
Ras homolog enriched in brain
|
|
RHEBL1
|
Ras homolog enriched in brain like 1
|
|
RHEBP1
|
Ras-homolog enriched in brain pseudogene 1
|
|
RHOA
|
ras homolog family member A
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
|
RIOK1
|
RIO kinase 1
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RPS6KB2
|
ribosomal protein S6 kinase, 70kDa, polypeptide 2
|
|
RPTOR
|
regulatory associated protein of MTOR, complex 1
|
|
SACK1D
|
scaffolding CK1 anchoring protein D
|
|
SESN2
|
sestrin 2
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SIRT1
|
sirtuin 1
|
|
SLC1A1
|
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1
|
|
SMAD1
|
SMAD family member 1
|
|
SMAD5
|
SMAD family member 5
|
|
SMAD9
|
SMAD family member 9
|
|
SMG1
|
SMG1 phosphatidylinositol 3-kinase-related kinase
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SMURF2
|
SMAD specific E3 ubiquitin protein ligase 2
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SPAG5
|
sperm associated antigen 5
|
|
SQSTM1
|
sequestosome 1
|
|
SRPK1
|
SRSF protein kinase 1
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STK11
|
serine/threonine kinase 11
|
|
STK4
|
serine/threonine kinase 4
|
|
TBCK
|
TBC1 domain containing kinase
|
|
TBK1
|
TANK-binding kinase 1
|
|
TELO2
|
telomere maintenance 2
|
|
TERT
|
telomerase reverse transcriptase
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THPO
|
thrombopoietin
|
|
TLR4
|
toll-like receptor 4
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TWIST2
|
twist family bHLH transcription factor 2
|
|
TXNIP
|
thioredoxin interacting protein
|
|
UBR5
|
ubiquitin protein ligase E3 component n-recognin 5
|
|
ULK1
|
unc-51 like autophagy activating kinase 1
|
|
ULK2
|
unc-51 like autophagy activating kinase 2
|
|
UPF2
|
UPF2 regulator of nonsense transcripts homolog (yeast)
|
|
USP9X
|
ubiquitin specific peptidase 9, X-linked
|
|
VCP
|
valosin containing protein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VTN
|
vitronectin
|
|
YAP1
|
Yes-associated protein 1
|
